1. Home
  2. WBX vs PGEN Comparison

WBX vs PGEN Comparison

Compare WBX & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

HOLD

Current Price

$2.94

Market Cap

45.0M

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.12

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WBX
PGEN
Founded
2015
1998
Country
Spain
United States
Employees
1108
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
1.4B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
WBX
PGEN
Price
$2.94
$4.12
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
$4.75
$8.33
AVG Volume (30 Days)
17.7K
5.1M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$60.77
$1,115.92
Revenue Next Year
$49.46
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$1.12
52 Week High
$7.83
$5.47

Technical Indicators

Market Signals
Indicator
WBX
PGEN
Relative Strength Index (RSI) 50.04 57.79
Support Level $2.30 $4.02
Resistance Level $3.21 $4.44
Average True Range (ATR) 0.22 0.31
MACD 0.06 0.12
Stochastic Oscillator 39.71 87.04

Price Performance

Historical Comparison
WBX
PGEN

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: